In the face of fierce market competition, Health Yuan Pharmaceutical Group aims at continuous innovation, honesty and trustworthiness, and caring for public health, focusing on the field of medicine and health care products, and comprehensively building a medical platform for raw materials, OTC, prescription drugs and health care products. Taitai Pharmaceutical will take the female products as the main direction, such as gynecological and female products with Taitai oral liquid as the core and Jingxin oral liquid as the core. Health Pharmaceutical (China) will focus on Eagle Ginseng series products and position itself as an enterprise that produces and manages high-grade tonics; Joy industry will expand its products in mass nutrition and tonics; Shandong Health will take new skin and full spirit as the leading factor and extend skin products. Haibin pharmaceutical will still focus on antibiotics and fully develop prescription drugs; Livzon Group will give full play to its absolute advantage in prescription drugs and build a brand army. In the future, Health Yuan will develop in an all-round way with the cooperation of its subsidiaries, build brand awareness by relying on technological innovation, and strive to become the top five pharmaceutical companies in China within 5- 10 years.
Our company, formerly known as "Shenzhen Amir Food Co., Ltd.", was formally established as a Sino-foreign joint venture with the approval of Shenzhen Administration for Industry and Commerce on 1992 12 18, mainly engaged in the production and sales of Taitai oral liquid. 1994 65438+1October19, and the company was renamed as "Shenzhen Taitai Health Food Co., Ltd.". 1July 4, 995, the company was renamed as "Shenzhen Taitai Pharmaceutical Co., Ltd.". 1September 999 16 and11October 10 were resolved by the shareholders' meeting of the company and deeply replied by the Shenzhen Municipal People's Government (1999)1. The company was renamed as "Shenzhen Taitai Pharmaceutical Co., Ltd." on June 24th, 1999+065438. On February 6th, 20001,China Securities Regulatory Commission issued the Notice on Approving the Public Offering of Shenzhen Taitai Pharmaceutical Co., Ltd. with document [200 1] 21,and agreed that the company would publicly issue domestic listed domestic shares (A shares) to the public. On June 8, 20001year, the company's shares were listed and traded on the Shanghai Stock Exchange. On June 4, 2003, the company changed its name to "Shenzhen Health Pharmaceutical Group Co., Ltd.". On September 29th of the same year, the company was renamed as "Healthy Yuan Pharmaceutical Group Co., Ltd.".